nach oben

The European Journal of Health Economics

Erschienen in:

01.05.2014 | Original Paper

Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries

verfasst von: Márta Péntek, Gyula Poór, Piotr Wiland, Martina Olejárová, Marek Brzosko, Catalin Codreanu, Nóra Brodszky, László Gulácsi

Erschienen in: The European Journal of Health Economics | Sonderheft 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Biological drugs revolutionized the treatment of inflammatory rheumatic diseases. Access to treatment presents substantial variability across Europe. The economic level of a particular country as well as administrative restrictions have been proved as determining factors of biological drug uptake. The objective of this paper was to provide an overview of biological treatment in six selected Central and Eastern European (CEE) countries, namely in the Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovakia. The literature is summarized with regard to the epidemiology, disease burden and use of biological agents in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Moreover, an estimate is provided on the prevalence and number of patients with biological treatment based on international and local sources. In view of the limited availability of information and uncertainty in data, there is an urgent need for development of systematic and comprehensive data collection in inflammatory rheumatic diseases in CEE countries.

Source: ATTRA registry, available at www.attra.registry.cz.

The validity of IMS data are not known due to the fact that IMS data covers the retail channel only, a number of companies deliver products directly to hospitals without other distribution channels, and secondly a significant proportion of biologicals are re-exported (parallel export).

Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham 3rd, C.O., Birnbaum, N.S., Burmester, G.R., Bykerk, V.P., Cohen, M.D., Combe, B., Costenbader, K.H., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J.M., Hobbs, K., Huizinga, T.W., Kavanaugh, A., Kay, J., Kvien, T.K., Laing, T., Mease, P., Menard, H.A., Moreland, L.W., Naden, R.L., Pincus, T., Smolen, J.S., Stanislawska-Biernat, E., Symmons, D., Tak, P.P., Upchurch, K.S., Vencovsky, J., Wolfe, F., Hawker, G.: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 69(9), 1580–1588 (2010)PubMedCrossRef

Nikolaus, S., Bode, C., Taal, E., van de Laar, M.A.: Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res. (Hoboken) 65(7), 1128–1146 (2013)CrossRef

Matcham, F., Rayner, L., Steer, S., Hotopf, M.: The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxf.) 52(12), 2136–2148 (2013)CrossRef

Szekanecz, Z., Koch, A.E.: Vascular involvement in rheumatic diseases: ‘vascular rheumatology’. Arthritis Res. Ther. 10(5), 224 (2008)PubMedCentralPubMedCrossRef

Humphreys, J.H., Warner, A., Chipping, J., Marshall, T., Lunt, M., Symmons, D.P., Verstappen, S.M.: Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register. Arthritis Care Res. (Hoboken) (2014). doi:10.1002/acr.22296

Braun, J., Sieper, J.: Ankylosing spondylitis. Lancet 369(9570), 1379–1390 (2007)PubMedCrossRef

El Maghraoui, A.: Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur. J. Intern. Med. 22(6), 554–560 (2011)PubMedCrossRef

Sieper, J., Braun, J., Rudwaleit, M., Boonen, A., Zink, A.: Ankylosing spondylitis: an overview. Ann. Rheum. Dis. 61(Suppl. 3), iii8–iii18 (2002)PubMedCentralPubMed

Mease, P.: Psoriatic arthritis and spondyloarthritis assessment and management update. Curr. Opin. Rheumatol. 25(3), 287–296 (2013)PubMedCrossRef

10.

Cortesi, P.A., Scalone, L., D’Angiolella, L., Belisari, A., Fusco, F., Olivieri, I., Mantovani, L.G.: Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis. Clin. Exp. Rheumatol. 30(4 Suppl. 73), S126–S131 (2012)PubMed

11.

Arumugam, R., McHugh, N.J.: Mortality and causes of death in psoriatic arthritis. J. Rheumatol. Suppl. 89, 32–35 (2012)PubMedCrossRef

12.

Beukelman, T., Patkar, N.M., Saag, K.G., Tolleson-Rinehart, S., Cron, R.Q., DeWitt, E.M., Ilowite, N.T., Kimura, Y., Laxer, R.M., Lovell, D.J., Martini, A., Rabinovich, C.E., Ruperto, N.: 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. (Hoboken) 63(4), 465–482 (2011)CrossRef

13.

Carmona, L., Cross, M., Williams, B., Lassere, M., March, L.: Rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 24(6), 733–745 (2010)PubMedCrossRef

14.

Rudwaleit, M., van der Heijde, D., Landewé, R., Listing, J., Akkoc, N., Brandt, J., Braun, J., Chou, C.T., Collantes-Estevez, E., Dougados, M., Huang, F., Gu, J., Khan, M.A., Kirazli, Y., Maksymowych, W.P., Mielants, H., Sørensen, I.J., Ozgocmen, S., Roussou, E., Valle-Oñate, R., Weber, U., Wei, J., Sieper, J.: The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann. Rheum. Dis. 68(6), 773–783 (2009)

15.

Alamanos, Y., Voulgari, P.V., Drosos, A.A.: Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin. Arthritis Rheum. 36(3), 182–188 (2006)PubMedCrossRef

16.

Kiss, C.G., Lovei, C., Suto, G., Varju, C., Nagy, Z., Fuzesi, Z., Illes, T., Czirjak, L.: Prevalence of rheumatoid arthritis in the South-Transdanubian region of Hungary based on a representative survey of 10,000 inhabitants. J. Rheumatol. 32(9), 1688–1690 (2005)PubMed

17.

Hanova, P., Pavelka, K., Dostal, C., Holcatova, I., Pikhart, H.: Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002–2003. Clin. Exp. Rheumatol. 24(5), 499–507 (2006)PubMed

18.

Sebestyen, A., Boncz, I., Sandor, J., Nyarady, J.: Effect of surgical delay on early mortality in patients with femoral neck fracture. Int. Orthop. 32(3), 375–379 (2008)PubMedCentralPubMedCrossRef

19.

Molics, B., Kranicz, J., Schmidt, B., Sebestyen, A., Nyarady, J., Boncz, I.: Utilization of physiotherapy services for traumatic disorders of the lower extremity in ambulatory care. Orv. Hetil. 154(25), 985–992 (2013)PubMedCrossRef

20.

Lepp-Gazdag, A., Gulácsi, L., Brandtmüller, Á.: A rheumatoid arthritis megbetegedés és ellátás jellemzői Magyarországon. Egészségügyi Gazdasági Szemle 40(6), 645–657 (2002)

21.

Héjj, G.: Reumatológia a számok tükrében. Magyar Reumatológia 49(2), 70–82 (2008)

22.

Boncz, I., Dobrossy, L., Pentek, Z., Kovacs, A., Budai, A., Imre, L., Vajda, R., Sebestyen, A.: Attendance of the fourth (2008–2009) screening round of the Hungarian organized, nationwide breast cancer screening program. Orv. Hetil. 154(50), 1975–1983 (2013)PubMedCrossRef

23.

Kovacs, A., Dobrossy, L., Budai, A., Boncz, I., Cornides, A.: Cervical screening in Hungary: why does the “English model” work but the “Hungarian model” does not? Eur. J. Gynaecol. Oncol. 29(1), 5–9 (2008)PubMed

24.

Dean, L.E., Jones, G.T., Macdonald, A.G., Downham, C., Sturrock, R.D., Macfarlane, G.J.: Global prevalence of ankylosing spondylitis. Rheumatology (Oxf.) 53(4), 650–657 (2014)CrossRef

25.

Hanova, P., Pavelka, K., Holcatova, I., Pikhart, H.: Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand. J. Rheumatol. 39(4), 310–317 (2010)PubMedCrossRef

26.

Tigau, M.M., Manole, A., Manole, M., Trifan, M.: Multidisciplinary prospective epidemiological research regarding the prevalence of ankylosing spondilytis, comparatively in Romania and Iasi County, between 1990–2006. Rev. Med. Chir. Soc. Med. Nat. Iasi 112(2), 502–506 (2008)PubMed

27.

Tigau, M.M., Rezus, E., Manole, A., Matei, M., Ivan, A.: Clinical epidemiologic study of admissions for ankylosing spondilitis at the Clinic of Rheumatology and Medical Rehabilitation, Hospital of Rehabilitation Iasi, between 1990 and 2007. Rev. Med. Chir. Soc. Med. Nat. Iasi 113(1), 79–83 (2009)PubMed

28.

Catanoso, M., Pipitone, N., Salvarani, C.: Epidemiology of psoriatic arthritis. Reumatismo 64(2), 66–70 (2012)PubMedCrossRef

29.

Bakland, G., Nossent, H.C.: Epidemiology of spondyloarthritis: a review. Curr. Rheumatol. Rep. 15(9), 351 (2013)PubMedCrossRef

30.

Lundkvist, J., Kastang, F., Kobelt, G.: The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur. J. Health Econ. 8(Suppl. 2), S49–S60 (2008)PubMedCrossRef

31.

Orlewska, E., Ancuta, I., Anic, B., Codrenau, C., Damjanov, N., Djukic, P., Ionescu, R., Marinchev, L., Nasonov, E.L., Peets, T., Praprotnik, S., Rashkov, R., Skoupa, J., Tlustochowicz, W., Tlustochowicz, M., Tomsic, M., Veldi, T., Vojinovic, J., Wiland, P.: Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries. Med. Sci. Monit. 17(4), SR1–SR13 (2011)PubMedCentralPubMedCrossRef

32.

Sokka, T., Kautiainen, H., Pincus, T., Verstappen, S.M., Aggarwal, A., Alten, R., Andersone, D., Badsha, H., Baecklund, E., Belmonte, M., Craig-Muller, J., da Mota, L.M., Dimic, A., Fathi, N.A., Ferraccioli, G., Fukuda, W., Geher, P., Gogus, F., Hajjaj-Hassouni, N., Hamoud, H., Haugeberg, G., Henrohn, D., Horslev-Petersen, K., Ionescu, R., Karateew, D., Kuuse, R., Laurindo, I.M., Lazovskis, J., Luukkainen, R., Mofti, A., Murphy, E., Nakajima, A., Oyoo, O., Pandya, S.C., Pohl, C., Predeteanu, D., Rexhepi, M., Rexhepi, S., Sharma, B., Shono, E., Sibilia, J., Sierakowski, S., Skopouli, F.N., Stropuviene, S., Toloza, S., Valter, I., Woolf, A., Yamanaka, H.: Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res. Ther. 12(2), R42 (2010)PubMedCentralPubMedCrossRef

33.

Boonen, A., Severens, J.L.: The burden of illness of rheumatoid arthritis. Clin. Rheumatol. 30(Suppl. 1), S3–S8 (2011)PubMedCrossRef

34.

Pentek, M., Kobelt, G., Czirjak, L., Szekanecz, Z., Poor, G., Rojkovich, B., Polgar, A., Genti, G., Kiss, C.G., Brodszky, V., Majer, I., Gulacsi, L.: Costs of rheumatoid arthritis in Hungary. J. Rheumatol. 34(6), 1437 (2007)PubMed

35.

Péntek, M., Rojkovich, B., Czirják, L., Géher, P., Keszthelyi, P., Kovács, A., Kovács, L., Náfrádi, L., Szanyó, F., Szekanecz, Z., Tamási, L., Tóth, E., Ujfalussy, I., Varju, T., Gulácsi, L.: Biológikumok Alkalmazása Rheumatoid Arthritisben—Terápiafelmérés (BARAT vizsgálat): biológiai terápiát kezdő betegek klinikai és egészségügyi szolgáltatások igénybevételének jelemzői. Immunológiai Szemle 3(4), 36–48 (2011)

36.

Boonen, A.: A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis. Nat. Clin. Pract. Rheumatol. 2(10), 546–553 (2006)PubMedCrossRef

37.

Palla, I., Trieste, L., Tani, C., Talarico, R., Cortesi, P.A., Mosca, M., Turchetti, G.: A systematic literature review of the economic impact of ankylosing spondylitis. Clin. Exp. Rheumatol. 30(4 Suppl. 73), S136–S141 (2012)PubMed

38.

Petrikova, A., Dolezal, T., Klimes, J., Vocelka, M., Sedova, L., Kolar, J.: The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008. Rheumatol. Int. 33(7), 1813–1819 (2013)PubMedCrossRef

39.

Geher, P.: Physiotherapy from the view of health insurance financing. Orv. Hetil. 154(48), 1917–1923 (2013)PubMedCrossRef

40.

Laki, J., Monok, G., Palosi, M., Gajdacsi, J.Z.: Economical aspect of biological therapy in inflammatory conditions in Hungary. Expert Opin. Biol. Ther. 13(3), 327–337 (2013)PubMedCrossRef

41.

Langham, S., Langham, J., Goertz, H.P., Ratcliffe, M.: Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: a systematic and critical review. BMC Med. Res. Methodol. 11, 32 (2011)PubMedCentralPubMedCrossRef

42.

Huscher, D., Merkesdal, S., Thiele, K., Zeidler, H., Schneider, M., Zink, A.: Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann. Rheum. Dis. 65(9), 1175–1183 (2006)PubMedCentralPubMedCrossRef

43.

Brodszky, V., Balint, P., Geher, P., Hodinka, L., Horvath, G., Koo, E., Pentek, M., Polgar, A., Sesztak, M., Szanto, S., Ujfalussy, I., Gulacsi, L.: Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment. Rheumatol. Int. 30(2), 199–205 (2009). doi:10.1007/s00296-009-0936-1 PubMedCrossRef

44.

Gulacsi, L., Orlewska, E., Pentek, M.: Health economics and health technology assessment in Central and Eastern Europe: a dose of reality. Eur. J. Health Econ. 13(5), 525–531 (2012)PubMedCrossRef

45.

Boncz, I., Nagy, J., Sebestyen, A., Korosi, L.: Financing of health care services in Hungary. Eur. J. Health Econ. 5(3), 252–258 (2004)PubMedCrossRef

46.

Wiland, P., Maciazek-Chyra, B.: Situation of rheumatology in Poland in 2012. Reumatologia 50(4), 263–275 (2012)

47.

Jönsson, B., Kobelt, G., Smolen, J.: The burden of rheumatoid arthritis and access to treatment: uptake of new therapies. Eur. J. Health Econ. 8(Suppl. 2), S61–S86 (2008)PubMedCrossRef

48.

Lundqvist, J., Kastang, F., Kobelt, G., Jonsson, B.: The burden of rheumatoid arthritis and access to treatment: determinants of access. Eur. J. Health Econ. 8(Suppl. 2), S87–S93 (2008)PubMedCrossRef

49.

Putrik, P., Ramiro, S., Kvien, T.K., Sokka, T., Pavlova, M., Uhlig, T., Boonen, A.: Inequities in access to biologic and synthetic DMARDs across 46 European countries. Ann. Rheum. Dis. 73(1), 198–206 (2014)PubMedCrossRef

50.

Rheumatology, R.S.f.: Protocol terapeutic in Poliartrita Reumatoida privind utilizarea agentilor biologici infliximabum, adalimumabum, etanerceptum, rituximabum. Monitorul Oficial al Romaniei, Partea I 238(bis/10.VI) (2010)

51.

Balanescu, A., Wiland, P.: Maximizing early treatment with biologics in patients with rheumatoid arthritis: the ultimate breakthrough in joints preservation. Rheumatol. Int. 33(6), 1379–1386 (2013)PubMedCrossRef

52.

Putrik, P., Ramiro, S., Kvien, T.K., Sokka, T., Uhlig, T., Boonen, A.: Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country’s wealth? Ann. Rheum. Dis. (2013). doi:10.1136/annrheumdis-2013-203819

53.

Sokka, T., Kautiainen, H., Pincus, T., Toloza, S., da Rocha Castelar Pinheiro, G., Lazovskis, J., Hetland, M.L., Peets, T., Immonen, K., Maillefert, J.F., Drosos, A.A., Alten, R., Pohl, C., Rojkovich, B., Bresnihan, B., Minnock, P., Cazzato, M., Bombardieri, S., Rexhepi, S., Rexhepi, M., Andersone, D., Stropuviene, S., Huisman, M., Sierakowski, S., Karateev, D., Skakic, V., Naranjo, A., Baecklund, E., Henrohn, D., Gogus, F., Badsha, H., Mofti, A., Taylor, P., McClinton, C., Yazici, Y.: Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann. Rheum. Dis. 68(11), 1666–1672 (2009)PubMedCentralPubMedCrossRef

54.

Boncz, I., Sebestyen, A.: Economy and mortality in Eastern and Western Europe between 1945 and 1990: the largest medical trial of history. Int. J. Epidemiol. 35(3), 796–797 (2006).; author reply 797–799PubMedCrossRef

55.

Szekanecz, Z.: Personalized medicine in rheumatology. Orv. Hetil. 154(13), 483–496 (2013)PubMedCrossRef

56.

Dostal, C., Pavelka, K., Zvarova, J., Hanzlicek, P., Olejarova, M.: Some principles of the development of a clinical database/national register of selected inflammatory rheumatic diseases in the Czech Republic. Int. J. Med. Inform. 75(3–4), 216–223 (2006)PubMedCrossRef

57.

Horak, P., Skacelova, M., Hejduk, K., Smrzova, A., Pavelka, K.: Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic — data from the ATTRA registry. Clin. Rheumatol. 32(10), 1451–1458 (2013)PubMedCrossRef

58.

Pavelka, K., Forejtova, S., Stolfa, J., Chroust, K., Buresova, L., Mann, H., Vencovsky, J.: Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA. Clin. Exp. Rheumatol. 27(6), 958–963 (2009)PubMed

59.

Ebner, W., Palotai, T., Codreanu, C., Geher, P., Pahor, A., Pavelka, K., Smolen, J., Szechinski, J., Zlnay, M.: Ankylosing spondylitis in Central and Eastern Europe. Cross-sectional study on treatment modalities, disease activity and quality of life. Z. Rheumatol. 67(6), 503–510 (2008)PubMedCrossRef

60.

Rybar, I., Rozborilova, E., Zanova, E., Micekova, D., Solovic, I., Rovensky, J.: The effectiveness for prevention of tuberculosis in patients with inflammatory rheumatic diseases treated with TNF inhibitors. Bratisl. Lek. Listy 109(4), 164–167 (2008)PubMed

61.

Mogosan, C., Stoica, V., Mihai, C., Macovei, L., Ancuta, I., Ciofu, C., Stefanescu, F., Bojinca, M., Martin, A., Milicescu, M., Crisan, V., Banciu, M., Suteanu, S.: Rheumatoid arthritis: travelling biological era a Romanian X-ray population. J. Med. Life 2(4), 414–425 (2009)PubMedCentralPubMed

62.

Mogosan, C., Stoica, V., Mihai, C., Ciofu, C., Bojinca, M., Milicescu, M., Crisan, V., Mioara, B.: Trends of rheumatoid arthritis monitorization in Romania. J. Med. Life 3(3), 330–337 (2010)PubMedCentralPubMed

63.

Costea, A.I., Ancuta, C., Chirieac, R.: Epidemiologic and functional aspects of rheumatoid arthritis in patients attending the Hospital Rehabilitation Clinic in Iasi, Romania. Rev. Med. Chir. Soc. Med. Nat. Iasi 115(4), 1219–1224 (2011)PubMed

64.

Pastragus, C., Ancuta, C., Miu, S.S., Belibou, I.C., Chirieac, R.: Descriptive assessments of a series of rheumatoid arthritis patients admitted to rehabilitation treatment between 2008 and 2010. Rev. Med. Chir. Soc. Med. Nat. Iasi 115(3), 762–768 (2011)PubMed

65.

Sallai, J.R., Hunka, A., Hejj, G., Ratko, I., Ortutay, J., Markus, I., Ormos, G., Ujfalussy, A., Szekeres, L., Insperger, A., Varju, T., Balint, G.: Survey of quality of life of rheumatoid arthritis patients admitted to rehabilitation centres in Hungary. Orv. Hetil. 154(35), 1381–1388 (2013)PubMedCrossRef

66.

Eurostat: Statistics. http://epp.eurostat.ec.europa.eu/portal/page/portal/statistics/search_database (2013)

67.

Stajszczyk, M.: Leczenie biologiczne w chorobach reumatycznych w Polsce - listopad 2013 [Biological treatment in rheumatic diseases in Poland]. In: Materials of the Conference, Polish Society of Rheumatology, pp. 2–20 (2013)

Titel: Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
verfasst von: Márta Péntek
Gyula Poór
Piotr Wiland
Martina Olejárová
Marek Brzosko
Catalin Codreanu
Nóra Brodszky
László Gulácsi
Publikationsdatum: 01.05.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: The European Journal of Health Economics / Ausgabe Sonderheft 1/2014
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-014-0592-6

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2014

Changes in the health status of the population of Central and Eastern European countries between 1990 and 2010

Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis

Statistical and regulatory considerations in assessments of interchangeability of biological drug products

Economic burden of long-term care of rheumatoid arthritis patients in Hungary

Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries

Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries